News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Inflammation is a novel target for therapeutic interventions in myeloid neoplasms – Uwe Platzbecker
Photo of Uwe Platzbecker from aml-hub.com
Jul 9, 2023, 09:28

Inflammation is a novel target for therapeutic interventions in myeloid neoplasms – Uwe Platzbecker

Inflammation is a novel target for therapeutic interventions in myeloid neoplasms. Specific subsets of LR-MDS may benefit and others may probably not. More work needed to better understand. Thanks to Marie Schneider, Clara Rolfs, Michael Cross and the entire MDS team!

For article: Click here

Source:

cancer cancer care Clara Rolfs Marie Schneider Michael Cross myeloid neoplasms OncoDaily Oncology Uwe Platzbecker
Special Coverage
Voices
Aug 21, 2025, 11:40
FDA has Granted Full Market Approval for Papzimeos - NIH
Insight
Aug 21, 2025, 11:16
Kefah Mokbel: TAD Proven Safe with Effective Long-Term Outcomes for Breast Cancer Patients
Voices
Aug 21, 2025, 11:15
Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...
OncoDaily Pulse
Aug 21, 2025, 10:23
Archana Ajmera: Meet the Experts of VIRO 2025
OncoDaily Pulse
Aug 21, 2025, 10:08
Yüksel Ürün: Meet the Experts of VIRO 2025
Voices
Aug 21, 2025, 09:46
Pratiti Bandopadhayay: Urgent Need to Sustain Funding for Pediatric Brain Tumor Trials
Voices
Aug 21, 2025, 09:30
Jana Ellegast: Inflammatory Signaling in the Pathogenesis of AML
Insight
Aug 21, 2025, 09:02
Humaid Al-Shamsi: Outcomes of HSCT from Matched Related Donors in Pediatric Patients
Celebrities
Aug 21, 2025, 08:40
World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer
Insight
Aug 21, 2025, 08:17
Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark
Science
Aug 21, 2025, 06:29
Moazzam Shahzad: The Impact of MRD Status after Matched Donor alloHCT in AML
Insight
Aug 21, 2025, 00:36
Tom Powles: IMVIGOR011 Trial Brings ctDNA-Guided Adjuvant Immunotherapy to Bladder Cancer